Valérie Rigau

10PUBLICATIONS
69CO-AUTHORS
Predictive and prognostic markersGene and molecular therapyHaematological tumoursMedical infection agents (incl. prions)Central nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 12, 2026
Modeling tumor volume trajectory and outcome identifies 3 distinct response classes in lower-grade IDH-mutant glioma receiving first-line chemotherapy.

|Mar 05, 2025
Clinical value of the MGMT promoter methylation score in IDHmt low-grade glioma for predicting benefit from temozolomide treatment.

Amélie Darlix, Pierre Bady, Jérémy Deverdun

|Dec 28, 2024
Nanopore sequencing as a cutting-edge technology for medulloblastoma classification.

Mathilde Filser, Jacob Torrejon, Kevin Merchadou

|Aug 02, 2024
Descriptive epidemiology of 399 histologically confirmed newly diagnosed meningeal solitary fibrous tumours and haemangiopericytomas in France: 2006-2015.

Charles Champeaux Depond, Sonia Zouaoui, Amélie Darlix

|May 13, 2024
Descriptive epidemiology of 30,223 histopathologically confirmed meningiomas in France: 2006-2015.

Charles Champeaux Depond, Sonia Zouaoui, Amélie Darlix

|Apr 26, 2024
CD138 as a Specific CSF Biomarker of Multiple Sclerosis.

Geoffrey Hinsinger, Lucile Du Trieu De Terdonck, Serge Urbach

Pageof 2

Frequent Collaborators

4 joint publications

Amélie Darlix

3 joint publications

Hugues Duffau

3 joint publications

Luc Bauchet

2 joint publications

Mohamed Khettab